Last updated 2026-06-18
- Raised funding round
Total raised
—
Last:
Stage
Mature
Founded
2012
Headcount
31
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Ayana Pharma develops liposome-based treatments for cancer. Ayana was formed to leverage the benefits of the anticancer drug Doxil, an FDA-approved liposomal nanodrug that has been used in the treatment of ovarian cancer, metastatic breast cancer, AIDS-related Kaposis sarcoma, and multiple myeloma. Co-founded by one of Doxils co-inventors, Professor Yechezkel Barenholz from the Hebrew University, the company is working to expand its treatment uses and efficacy while making it more readily available to address a range of conditions. Ayana has completed fundraising to support an abbreviated new drug application (ANDA), filing, and commercialization.
Funding history · 1 round · — total
Date unknown
Undisclosed
Q&A
- What is Ayana Pharma's primary focus?
- Ayana Pharma specializes in developing liposome-based treatments for cancer, leveraging the technology of the FDA-approved drug Doxil.
- When was Ayana Pharma founded?
- Ayana Pharma was founded in June 2012.
- Who co-founded Ayana Pharma?
- Ayana Pharma was co-founded by Professor Yechezkel Barenholz, one of the co-inventors of Doxil from the Hebrew University.
- What is Ayana Pharma's employee count?
- Ayana Pharma has an employee count in the 11-50 range.
- What is Ayana Pharma's current product stage?
- Ayana Pharma's product is currently in the released stage.
- What is Ayana Pharma's primary sector?
- Ayana Pharma's primary sector is Health Tech & Life Sciences.
- Which investors have participated in Ayana Pharma's funding rounds?
- Investors in Ayana Pharma's funding rounds include Integra Holdings.
- What is Ayana Pharma's current stage according to startupim data?
- Ayana Pharma is currently classified as a Mature company.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersPatients
Business model
B2B
Tags
cancergeneric-drugsmedical-technologiesdrug-deliveryspace-techpharmaceuticalshospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ayanapharma.com/ |
|---|
Identifiers & details
| Former names | DoxoCure |
|---|---|
| Founded | 2012-6 |
| Employees (exact) | 31 |
Radar intelligence
Web history (Wayback)
| Domain | ayanapharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|